Bellevue Life Sciences Acquisition Quick Ratio (BLAC) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Bellevue Life Sciences Acquisition Corp  (NASDAQ: BLAC)

Bellevue Life Sciences Acquisition's Quick Ratio

BLAC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 0.1 below Bellevue Life Sciences Acquisition Corp average.

Within Medical Equipment & Supplies industry 185 other companies have achieved higher Quick Ratio than Bellevue Life Sciences Acquisition in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 3851, from total ranking in the first quarter 2026 at 4585.

Explain Quick Ratio?
How much Cash & cash equivalents BLAC´s has?
What are BLAC´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BLAC Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2
Y / Y Current Liabilities Change 17.85 % 38.72 % 246.9 % 217.76 % 290.6 %
Y / Y Cash & cash equivalent Change -5.35 % -1.82 % 2470.95 % 17694.29 % 1230.14 %
Quick Ratio MRQ 0.1 0.1 0.12 0.17 0.12
BLAC's Total Ranking # 3851 # 4585 # 4116 # 4457 # 4363
Seq. Current Liabilities Change 0.56 % 10.76 % 12.81 % -6.2 % 18.37 %
Seq. Cash & cash equivalent Change -4.28 % -7.86 % -21.91 % 37.42 % -0.71 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 186
Healthcare Sector # 856
Overall Market # 3812


Quick Ratio Statistics
High Average Low
1.71 0.22 0
(Dec 31 2021)   (Mar 31 2024)




Financial Statements
Bellevue Life Sciences Acquisition's Current Liabilities $ 16 Millions Visit BLAC's Balance sheet
Bellevue Life Sciences Acquisition's Cash & cash equivalent $ 1 Millions Visit BLAC's Balance sheet
Source of BLAC's Sales Visit BLAC's Sales by Geography


Cumulative Bellevue Life Sciences Acquisition's Quick Ratio

BLAC's Quick Ratio for the trailling 12 Months

BLAC Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 77.77 % 145.03 % 261.72 % 241.54 % 253.49 %
Y / Y Cash & cash equivalent TTM Growth 113.1 % 291.97 % 3409.13 % 3506.35 % 1561.57 %
Quick Ratio TTM 0.12 0.13 0.14 0.13 0.1
Total Ranking TTM # 3244 # 3746 # 2869 # 3033 # 3159
Seq. Current Liabilities TTM Growth 4.28 % 8.52 % 24.39 % 26.29 % 43.74 %
Seq. Cash & cash equivalent TTM Growth -1.21 % -0.41 % 30.13 % 66.44 % 81.71 %

Quick ratio ranking by company, industry and sector >> Back to BLAC Financial Strength Comparisons >> Go to Compare BLAC Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q2 2026 to $15.73 millions, cumulative Quick Ratio decreased to 0.12 above the BLAC average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 206 other companies have achieved higher Quick Ratio than Bellevue Life Sciences Acquisition. While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2026 at 3048.

Explain Quick Ratio?
How much Cash & cash equivalents BLAC´s has?
What are BLAC´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 207
Healthcare Sector # 911
Within the Market # 3851


trailing twelve months Quick Ratio Statistics
High Average Low
0.16 0.08 0.01
(Sep 30 2023)   (Mar 31 2024)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Cytosorbents Corporation  0.24 $ 4.413  Millions$ 18.320  Millions
U S Physical Therapy Inc  0.23 $ 24.887  Millions$ 109.909  Millions
Accuray Incorporated  0.21 $ 40.623  Millions$ 191.405  Millions
Cerus Corporation  0.21 $ 17.980  Millions$ 85.790  Millions
Tenon Medical Inc   0.20 $ 1.677  Millions$ 8.305  Millions
Bioventus Inc   0.19 $ 29.457  Millions$ 154.471  Millions
Avita Medical Inc   0.19 $ 13.096  Millions$ 68.714  Millions
Bausch and Lomb Corp  0.19 $ 367.000  Millions$ 1,942.000  Millions
Dentsply Sirona Inc   0.18 $ 239.000  Millions$ 1,319.000  Millions
Adm Tronics Unlimited Inc   0.18 $ 0.223  Millions$ 1.235  Millions
Catheter Precision Inc   0.16 $ 1.839  Millions$ 11.166  Millions
Zimmer Biomet Holdings Inc   0.14 $ 410.000  Millions$ 3,013.500  Millions
Nexgel Inc   0.12 $ 1.692  Millions$ 14.440  Millions
Ufp Technologies Inc   0.12 $ 9.045  Millions$ 78.304  Millions
Solventum Corporation  0.11 $ 403.000  Millions$ 3,663.000  Millions
Nakamoto Inc   0.11 $ 19.072  Millions$ 179.474  Millions
Petvivo Holdings Inc   0.10 $ 0.135  Millions$ 1.313  Millions
The Pennant Group Inc   0.10 $ 15.273  Millions$ 152.406  Millions
Non Invasive Monitoring Systems Inc  0.10 $ 0.160  Millions$ 1.607  Millions
Boston Scientific Corporation  0.10 $ 749.000  Millions$ 7,530.000  Millions
Integer Holdings Corporation  0.10 $ 21.375  Millions$ 217.141  Millions
Bellevue Life Sciences Acquisition Corp  0.10 $ 1.500  Millions$ 15.734  Millions
National Vision Holdings Inc   0.09 $ 35.998  Millions$ 383.026  Millions
Becton Dickinson And Company  0.09 $ 864.000  Millions$ 9,404.000  Millions
Vivos Therapeutics Inc   0.09 $ 1.774  Millions$ 20.389  Millions
The Cooper Companies Inc   0.08 $ 154.900  Millions$ 1,866.600  Millions
Infusystem Holdings Inc  0.06 $ 0.964  Millions$ 15.300  Millions
Vsee Health Inc   0.06 $ 0.454  Millions$ 8.139  Millions
P3 Health Partners Inc   0.05 $ 21.272  Millions$ 388.581  Millions
Henry Schein Inc   0.05 $ 157.000  Millions$ 3,488.000  Millions

Date modified: 2026-09-26T07:42:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.